Search

everythinglearnresearchcommunity

for

Search:↓

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

Reproductive hormones play a crucial role in breast cancer development and treatment challenges.

Alopecia from CDK 4/6 inhibitors worsens quality of life in breast cancer patients.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Some breast cancer patients on hormonal therapy may develop male or female pattern hair loss, which can sometimes be improved with topical treatments.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

Nutraceuticals that promote hair growth do not reduce tamoxifen's effectiveness in breast cancer treatment.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Melatonin affects many body functions beyond sleep by interacting with specific receptors in various tissues.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Both estrogens and androgens are important for health in both males and females.

Patients with HR+/HER2- advanced breast cancer commonly experience fatigue, hair loss, and pain, which significantly affect daily activities.

Patients with advanced breast cancer prioritize quality of life, overall survival, and progression-free survival in treatment decisions.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Patients prioritize quality of life, overall survival, and progression-free survival in treatment decisions for advanced breast cancer.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

Some hormone treatments might raise breast cancer risk, while others don't seem to.

Oestrogens help maintain healthy skin, heal wounds, and may protect against skin aging and cancer.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

Quality of life, overall survival, and progression-free survival should be equally prioritized in advanced breast cancer treatment decisions.